Skip to main content

Find Clinical Trials

Home
Conditions
Neutropenia

Clinical trial condition

Neutropenia

Explore clinical trials studying Neutropenia. Study availability and eligibility vary by location and protocol.

132 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Neutropenia trial results

Completed

AMD 3100 for Treatment of Myelokathexis

NCT01058993

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +5 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia

NCT00002693

Conditions: Agranulocytosis, Blast Crisis, Bone Marrow Diseases, +27 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

The Tobramycin Study

NCT00257790

Conditions: Agranulocytosis, Body Temperature Changes, Cancer, +10 more
Locations: Not specified

View Trial Details

Completed

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

NCT00771433

Conditions: Agranulocytosis, Breast Cancer, Breast Diseases, +12 more
Locations: Centre Regional Francois Baclesse Caen, France

View Trial Details

Completed

G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy

NCT00770172

Conditions: Agranulocytosis, Chemotherapeutic Agent Toxicity, Cytopenia, +6 more
Locations: Centre Regional Francois Baclesse Caen, France

View Trial Details

Completed

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

NCT00174473

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

NCT00497809

Conditions: Agranulocytosis, Breast Cancer, Breast Diseases, +11 more
Locations: Pacific Cancer Medical Center Anaheim, California, United States

California Cancer Center Greenbrae, California, United States

Ghassan Al-Jazayrly, MD, Inc. Los Angeles, California, United States

Desert Hematology Oncology Medical Group Rancho Mirage, California, United States

View all 31 locations

View Trial Details

Completed

Safety of Cotrimoxazole in HIV- and HAART-exposed Infants

NCT01086878

Conditions: Acquired Immunodeficiency Syndrome, Agranulocytosis, Anemia, +22 more
Locations: Princess Marina Hospital Gaborone, Botswana

Scottish Livingstone Hospital Molepolole, Kweneng District, Botswana

View Trial Details

Completed

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

NCT00125723

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

NCT00277160

Conditions: Adnexal Diseases, Agranulocytosis, Breast Cancer, +39 more
Locations: Not specified

View Trial Details